Return On Equity of REGENXBIO Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
REGENXBIO Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • REGENXBIO Inc. Return On Equity for the quarter ending 30 Sep 2025 was -78%, a 11% decline year-over-year.
  • REGENXBIO Inc. annual Return On Equity for 2024 was -70%, a 2.5% decline from 2023.
  • REGENXBIO Inc. annual Return On Equity for 2023 was -68%, a 46% decline from 2022.
  • REGENXBIO Inc. annual Return On Equity for 2022 was -47%, a 309% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

REGENXBIO Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -78% -8% -11% 01 Jul 2025 30 Sep 2025
Q2 2025 -67% +1% +1.8% 01 Apr 2025 30 Jun 2025
Q1 2025 -53% +17% +25% 01 Jan 2025 31 Mar 2025
Q4 2024 -70% -2% -2.5% 01 Oct 2024 31 Dec 2024
Q3 2024 -71% -11% -19% 01 Jul 2024 30 Sep 2024
Q2 2024 -68% -12% -21% 01 Apr 2024 30 Jun 2024
Q1 2024 -71% -21% -42% 01 Jan 2024 31 Mar 2024
Q4 2023 -68% -21% -46% 01 Oct 2023 31 Dec 2023
Q3 2023 -60% -71% -635% 01 Jul 2023 30 Sep 2023
Q2 2023 -56% -70% -494% 01 Apr 2023 30 Jun 2023
Q1 2023 -50% -66% -397% 01 Jan 2023 31 Mar 2023
Q4 2022 -47% -69% -309% 01 Oct 2022 31 Dec 2022
Q3 2022 11% +56% 01 Jul 2022 30 Sep 2022
Q2 2022 14% +46% 01 Apr 2022 30 Jun 2022
Q1 2022 17% +45% 01 Jan 2022 31 Mar 2022
Q4 2021 22% +50% 01 Oct 2021 31 Dec 2021
Q3 2021 -45% -23% -106% 01 Jul 2021 30 Sep 2021
Q2 2021 -31% 0% -0.8% 01 Apr 2021 30 Jun 2021
Q1 2021 -28% -5% -24% 01 Jan 2021 31 Mar 2021
Q4 2020 -28% -8% -38% 01 Oct 2020 31 Dec 2020
Q3 2020 -22% -9% -66% 01 Jul 2020 30 Sep 2020
Q2 2020 -31% -21% -217% 01 Apr 2020 30 Jun 2020
Q1 2020 -22% -14% -177% 01 Jan 2020 31 Mar 2020
Q4 2019 -20% -45% -181% 01 Oct 2019 31 Dec 2019
Q3 2019 -13% -38% -153% 01 Jul 2019 30 Sep 2019
Q2 2019 -10% -41% -131% 01 Apr 2019 30 Jun 2019
Q1 2019 -8% -32% -134% 01 Jan 2019 31 Mar 2019
Q4 2018 25% +61% 01 Oct 2018 31 Dec 2018
Q3 2018 25% +64% 01 Jul 2018 30 Sep 2018
Q2 2018 31% +70% 01 Apr 2018 30 Jun 2018
Q1 2018 24% +63% 01 Jan 2018 31 Mar 2018
Q4 2017 -36% -3% -8.2% 01 Oct 2017 31 Dec 2017
Q3 2017 -39% -15% -62% 01 Jul 2017 30 Sep 2017
Q2 2017 -39% -21% -117% 01 Apr 2017 30 Jun 2017
Q1 2017 -40% 01 Jan 2017 31 Mar 2017
Q4 2016 -34% 01 Oct 2016 31 Dec 2016
Q3 2016 -24% 01 Jul 2016 30 Sep 2016
Q2 2016 -18% 01 Apr 2016 30 Jun 2016

REGENXBIO Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -70% -2% -2.5% 01 Jan 2024 31 Dec 2024
2023 -68% -21% -46% 01 Jan 2023 31 Dec 2023
2022 -47% -69% -309% 01 Jan 2022 31 Dec 2022
2021 22% +50% 01 Jan 2021 31 Dec 2021
2020 -28% -8% -38% 01 Jan 2020 31 Dec 2020
2019 -20% -45% -181% 01 Jan 2019 31 Dec 2019
2018 25% +61% 01 Jan 2018 31 Dec 2018
2017 -36% -3% -8.2% 01 Jan 2017 31 Dec 2017
2016 -34% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.